Differential patterns of replacement and reactive fibrosis in pressure and volume overload are related to the propensity for ischaemia and involve resistin

Journal of Physiology

Volumn 591, Issue 21, 2013, Pages 5337-5355

  Chemaly, Elie R ^a   Kang, Soojeong ^a   Zhang, Shihong ^a   Mccollum, Latronya ^a   Chen, Jiqiu ^a   Bénard, Ludovic ^a   Purushothaman, K Raman ^a   Hajjar, Roger J ^a   Lebeche, Djamel ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN II; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; GELATINASE A; MESSENGER RNA; RESISTIN; TRANSFORMING GROWTH FACTOR BETA; CTGF PROTEIN, RAT; MMP2 PROTEIN, RAT; RETN PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTOCAVAL FISTULA; ARTICLE; CAPILLARY DENSITY; COLLAGEN SYNTHESIS; COLLAGEN TYPE I GENE 1A1 GENE; COLLAGEN TYPE I GENE 3A1 GENE; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME ASSAY; GENE; GENE FUNCTION; GENE IDENTIFICATION; HEART HEMODYNAMICS; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE OVERLOAD; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; IN VITRO STUDY; MALE; MOLECULAR DYNAMICS; NONHUMAN; OXYGEN SUPPLY; PRESSURE OVERLOAD LEFT VENTRICULAR HYPERTROPHY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; QUANTITATIVE ANALYSIS; RAT; REACTIVE FIBROSIS; REPLACEMENT FIBROSIS; SIGNAL TRANSDUCTION; VOLUME OVERLOAD LEFT VENTRICULAR HYPERTROPHY; ANIMAL; CARDIAC MUSCLE CELL; FIBROSIS; GENETICS; HEART LEFT VENTRICLE FUNCTION; HEMODYNAMICS; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; CARDIOMYOPATHY, DILATED; COLLAGEN; CONNECTIVE TISSUE GROWTH FACTOR; FIBROSIS; HEMODYNAMICS; MALE; MATRIX METALLOPROTEINASE 2; MYOCARDIAL ISCHEMIA; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; RESISTIN; TRANSFORMING GROWTH FACTOR BETA; VENTRICULAR DYSFUNCTION, LEFT;

EID: 84886769543     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2013.258731     Document Type: Article

References (61)

1. Arias T, Chen J, Fayad ZA, Fuster V, Hajjar RJ & Chemaly ER (2013). Comparison of echocardiographic measurements of left ventricular volumes to full volume magnetic resonance imaging in normal and diseased rats. J Am Soc Echocardiogr 26, 910-918.
2. Bache RJ & Dai XZ (1990). Myocardial oxygen consumption during exercise in the presence of left ventricular hypertrophy secondary to supravalvular aortic stenosis. J Am Coll Cardiol 15, 1157-1164.
3. Beeri R, Yosefy C, Guerrero JL, Nesta F, Abedat S, Chaput M, del Monte F, Handschumacher MD, Stroud R, Sullivan S, Pugatsch T, Gilon D, Vlahakes GJ, Spinale FG, Hajjar RJ & Levine RA (2008). Mitral regurgitation augments post-myocardial infarction remodeling failure of hypertrophic compensation. J Am Coll Cardiol 51, 476-486.
4. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G & Anversa P (1994). Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 89, 151-163.
5. Borer JS, Herrold EM, Carter JN, Catanzaro DF & Supino PG (2006). Cellular and molecular basis of remodeling in valvular heart diseases. Heart Fail Clin 2, 415-424.
6. Borer JS, Truter S, Herrold EM, Falcone DJ, Pena M, Carter JN, Dumlao TF, Lee JA & Supino PG (2002). Myocardial fibrosis in chronic aortic regurgitation: molecular and cellular responses to volume overload. Circulation 105, 1837-1842.
7. Brower GL, Gardner JD, Forman MF, Murray DB, Voloshenyuk T, Levick SP & Janicki JS (2006). The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur J Cardiothorac Surg 30, 604-610.
8. Camici PG & Crea F (2007). Coronary microvascular dysfunction. N Engl J Med 356, 830-840.
9. Carabello BA (2012). Volume overload. Heart Fail Clin 8, 33-42.
10. Carabello BA, Nakano K, Ishihara K, Kanazawa S, Biederman RW & Spann JF Jr (1991). Coronary blood flow in dogs with contractile dysfunction due to experimental volume overload. Circulation 83, 1063-1075.
11. Chemaly ER, Chaanine AH, Sakata S & Hajjar RJ (2012). Stroke volume-to-wall stress ratio as a load-adjusted and stiffness-adjusted indicator of ventricular systolic performance in chronic loading. J Appl Physiol 113, 1267-1284.
12. Chemaly ER, Hadri L, Zhang S, Kim M, Kohlbrenner E, Sheng J, Liang L, Chen J, K-Raman P, Hajjar RJ & Lebeche D (2011). Long-term in vivo resistin overexpression induces myocardial dysfunction and remodeling in rats. J Mol Cell Cardiol 51, 144-155.
13. Chen J, Chemaly ER, Liang LF, LaRocca TJ, Yaniz-Galende E & Hajjar RJ (2011). A new model of congestive heart failure in rats. Am J Physiol Heart Circ Physiol 301, H994-H1003.
14. Coleman HN, Sonnenblick EH & Braunwald E (1969). Myocardial oxygen consumption associated with external work: the Fenn effect. Am J Physiol 217, 291-296.
15. Dorn GW 2nd (2007). The fuzzy logic of physiological cardiac hypertrophy. Hypertension 49, 962-970.
16. Duncker DJ & Bache RJ (2008). Regulation of coronary blood flow during exercise. Physiol Rev 88, 1009-1086.
17. Eckhouse SR & Spinale FG (2012). Changes in the myocardial interstitium and contribution to the progression of heart failure. Heart Fail Clin 8, 7-20.
18. Enriquez-Sarano M, Avierinos JF, Messika-Zeitoun D, Detaint D, Capps M, Nkomo V, Scott C, Schaff HV & Tajik AJ (2005). Quantitative determinants of the outcome of asymptomatic mitral regurgitation. N Engl J Med 352, 875-883.
19. Faris RF, Flather M, Purcell H, Poole-Wilson PA & Coats AJ (2012). Diuretics for heart failure. Cochrane Database Syst Rev 2, CD003838.
20. Frankel DS, Vasan RS, D'Agostino RB Sr, Benjamin EJ, Levy D, Wang TJ & Meigs JB (2009). Resistin, adiponectin, and risk of heart failure: the Framingham offspring study. J Am Coll Cardiol 53, 754-762.
21. Fuster V, Danielson MA, Robb RA, Broadbent JC, Brown AL Jr & Elveback LR (1977). Quantitation of left ventricular myocardial fiber hypertrophy and interstitial tissue in human hearts with chronically increased volume and pressure overload. Circulation 55, 504-508.
22. Grossman W, Jones D & McLaurin LP (1975). Wall stress and patterns of hypertrophy in the human left ventricle. J Clin Invest 56, 56-64.
23. Heymans S, Luttun A, Nuyens D, Theilmeier G, Creemers E, Moons L, Dyspersin GD, Cleutjens JP, Shipley M, Angellilo A, Levi M, Nube O, Baker A, Keshet E, Lupu F, Herbert JM, Smits JF, Shapiro SD, Baes M, Borgers M, Collen D, Daemen MJ & Carmeliet P (1999). Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med 5, 1135-1142.
24. Ho JE, Liu C, Lyass A, Courchesne P, Pencina MJ, Vasan RS, Larson MG & Levy D (2012). Galectin-3, a marker of cardiac fibrosis, predicts incident heart failure in the community. J Am Coll Cardiol 60, 1249-1256.
25. Hutchinson KR, Guggilam A, Cismowski MJ, Galantowicz ML, West TA, Stewart JA Jr, Zhang X, Lord KC & Lucchesi PA (2011). Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure. J Appl Physiol 111, 1778-1788.
26. Hutchinson KR, Stewart JA Jr & Lucchesi PA (2010). Extracellular matrix remodeling during the progression of volume overload-induced heart failure. J Mol Cell Cardiol 48, 564-569.
27. Kandalam V, Basu R, Moore L, Fan D, Wang X, Jaworski DM, Oudit GY & Kassiri Z (2011). Lack of tissue inhibitor of metalloproteinases 2 leads to exacerbated left ventricular dysfunction and adverse extracellular matrix remodeling in response to biomechanical stress. Circulation 124, 2094-2105.
28. Kang S, Chemaly ER, Hajjar RJ & Lebeche D (2011). Resistin promotes cardiac hypertrophy via the AMP-activated protein kinase/mammalian target of rapamycin (AMPK/mTOR) and c-Jun N-terminal kinase/insulin receptor substrate 1 (JNK/IRS1) pathways. J Biol Chem 286, 18465-18473.
29. Kehat I & Molkentin JD (2010). Molecular pathways underlying cardiac remodeling during pathophysiological stimulation. Circulation 122, 2727-2735.
30. Kim KH, Kim YJ, Lee SP, Kim HK, Seo JW, Sohn DW, Oh BH & Park YB (2011). Survival, exercise capacity, and left ventricular remodeling in a rat model of chronic mitral regurgitation: serial echocardiography and pressure-volume analysis. Korean Circ J 41, 603-611.
31. Kim M, Oh JK, Sakata S, Liang I, Park W, Hajjar RJ & Lebeche D (2008). Role of resistin in cardiac contractility and hypertrophy. J Mol Cell Cardiol 45, 270-280.
32. Kortekaas KA, Hoogslag GE, de Boer RA, Dokter MM, Versteegh MI, Braun J, Marsan NA, Verwey HF, Delgado V, Schalij MJ & Klautz RJ (2013). Galectin-3 and left ventricular reverse remodelling after surgical mitral valve repair. Eur J Heart Fail 15, 1011-1018.
33. Krysiak R, Sierant M, Marek B & Okopien B (2010). The effect of perindopril and enalapril on plasma resistin levels in normotensive patients with coronary heart disease. Endokrynol Pol 61, 683-690.
34. Leask A (2010). Potential therapeutic targets for cardiac fibrosis: TGFβ, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res 106, 1675-1680.
35. Lopes MM, Ribeiro GC, Tornatore TF, Clemente CF, Teixeira VP & Franchini KG (2007). Increased expression and phosphorylation of focal adhesion kinase correlates with dysfunction in the volume-overloaded human heart. Clin Sci (Lond) 113, 195-204.
36. Maron MS, Olivotto I, Maron BJ, Prasad SK, Cecchi F, Udelson JE & Camici PG (2009). The case for myocardial ischemia in hypertrophic cardiomyopathy. J Am Coll Cardiol 54, 866-875.
37. Mullens W, Abrahams Z, Francis GS, Sokos G, Starling RC, Young JB, Taylor DO & Tang WH (2009). Usefulness of isosorbide dinitrate and hydralazine as add-on therapy in patients discharged for advanced decompensated heart failure. Am J Cardiol 103, 1113-1119.
38. Nakanishi M, Harada M, Kishimoto I, Kuwahara K, Kawakami R, Nakagawa Y, Yasuno S, Usami S, Kinoshita H, Adachi Y, Fukamizu A, Saito Y & Nakao K (2007). Genetic disruption of angiotensin II type 1a receptor improves long-term survival of mice with chronic severe aortic regurgitation. Circ J 71, 1310-1316.
39. O'Keefe JH, Patil HR, Lavie CJ, Magalski A, Vogel RA & McCullough PA (2012). Potential adverse cardiovascular effects from excessive endurance exercise. Mayo Clin Proc 87, 587-595.
40. Peterson JT, Hallak H, Johnson L, Li H, O'Brien PM, Sliskovic DR, Bocan TM, Coker ML, Etoh T & Spinale FG (2001). Matrix metalloproteinase inhibition attenuates left ventricular remodeling and dysfunction in a rat model of progressive heart failure. Circulation 103, 2303-2309.
41. Piper C, Schultheiss HP, Akdemir D, Rudolf J, Horstkotte D & Pauschinger M (2003). Remodeling of the cardiac extracellular matrix differs between volume- and pressure-overloaded ventricles and is specific for each heart valve lesion. J Heart Valve Dis 12, 592-600.
42. Plante E, Lachance D, Champetier S, Drolet MC, Roussel E, Arsenault M & Couet J (2008). Benefits of long-term β-blockade in experimental chronic aortic regurgitation. Am J Physiol Heart Circ Physiol 294, H1888-H1895.
43. Plante E, Lachance D, Gaudreau M, Drolet MC, Roussel E, Arsenault M & Couet J (2004). Effectiveness of β-blockade in experimental chronic aortic regurgitation. Circulation 110, 1477-1483.
44. Rockman HA, Wachhorst SP, Mao L & Ross J Jr (1994). ANG II receptor blockade prevents ventricular hypertrophy and ANF gene expression with pressure overload in mice. Am J Physiol Heart Circ Physiol 266, H2468-H2475.
45. Rosenhek R, Binder T, Porenta G, Lang I, Christ G, Schemper M, Maurer G & Baumgartner H (2000). Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 343, 611-617.
46. Rosenhek R, Rader F, Klaar U, Gabriel H, Krejc M, Kalbeck D, Schemper M, Maurer G & Baumgartner H (2006). Outcome of watchful waiting in asymptomatic severe mitral regurgitation. Circulation 113, 2238-2244.
47. Rudolph A, Abdel-Aty H, Bohl S, Boyé P, Zagrosek A, Dietz R & Schulz-Menger J (2009). Noninvasive detection of fibrosis applying contrast-enhanced cardiac magnetic resonance in different forms of left ventricular hypertrophy: relation to remodeling. J Am Coll Cardiol 53, 284-291.
48. Ruzicka M, Yuan B, Harmsen E & Leenen FH (1993). The renin-angiotensin system and volume overload-induced cardiac hypertrophy in rats. Effects of angiotensin converting enzyme inhibitor versus angiotensin II receptor blocker. Circulation 87, 921-930.
49. Ryan TD, Rothstein EC, Aban I, Tallaj JA, Husain A, Lucchesi PA & Dell'Italia LJ (2007). Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. J Am Coll Cardiol 49, 811-821.
50. Sakata S, Lebeche D, Sakata N, Sakata Y, Chemaly ER, Liang LF, Tsuji T, Takewa Y, del Monte F, Peluso R, Zsebo K, Jeong D, Park WJ, Kawase Y & Hajjar RJ (2007). Restoration of mechanical and energetic function in failing aortic-banded rat hearts by gene transfer of calcium cycling proteins. J Mol Cell Cardiol 42, 852-861.
51. Schultz D, Su X, Wei CC, Bishop SP, Powell P, Hankes GH, Dillon AR, Rynders P, Spinale FG, Walcott G, Ideker R & Dell'Italia LJ (2002). Downregulation of ANG II receptor is associated with compensated pressure-overload hypertrophy in the young dog. Am J Physiol Heart Circ Physiol 282, H749-H756.
52. Schwartzkopff B, Frenzel H, Dieckerhoff J, Betz P, Flasshove M, Schulte HD, Mundhenke M, Motz W & Strauer BE (1992). Morphometric investigation of human myocardium in arterial hypertension and valvular aortic stenosis. Eur Heart J 13 (Suppl. D), 17-23.
53. Sharma UC, Pokharel S, van Brakel TJ, van Berlo JH, Cleutjens JP, Schroen B, Andre S, Crijns HJ, Gabius HJ, Maessen J & Pinto YM (2004). Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction. Circulation 110, 3121-3128.
54. Sparrow P, Messroghli DR, Reid S, Ridgway JP, Bainbridge G & Sivananthan MU (2006). Myocardial T1 mapping for detection of left ventricular myocardial fibrosis in chronic aortic regurgitation: pilot study. AJR Am J Roentgenol 187, W630-635.
55. Spinale FG (2011). Diversity of myocardial interstitial proteolytic pathways: gene deletion reveals unexpected consequences. Circulation 124, 2052-2055.
56. Takewa Y, Chemaly ER, Takaki M, Liang LF, Jin H, Karakikes I, Morel C, Taenaka Y, Tatsumi E & Hajjar RJ (2009). Mechanical work and energetic analysis of eccentric cardiac remodeling in a volume overload heart failure in rats. Am J Physiol Heart Circ Physiol 296, H1117-H1124.
57. Toischer K, Rokita AG, Unsold B, Zhu W, Kararigas G, Sossalla S, Reuter SP, Becker A, Teucher N, Seidler T, Grebe C, Preuss L, Gupta SN, Schmidt K, Lehnart SE, Kruger M, Linke WA, Backs J, Regitz-Zagrosek V, Schafer K, Field LJ, Maier LS & Hasenfuss G (2010). Differential cardiac remodeling in preload versus afterload. Circulation 122, 993-1003.
58. van den Borne SW, Diez J, Blankesteijn WM, Verjans J, Hofstra L & Narula J (2010). Myocardial remodeling after infarction: the role of myofibroblasts. Nat Rev Cardiol 7, 30-37.
59. Wei CC, Chen Y, Powell LC, Zheng J, Shi K, Bradley WE, Powell PC, Ahmad S, Ferrario CM & Dell'Italia LJ (2012). Cardiac kallikrein-kinin system is upregulated in chronic volume overload and mediates an inflammatory induced collagen loss. PLoS One 7, e40110.
60. Zendaoui A, Lachance D, Roussel E, Couet J & Arsenault M (2012). Effects of spironolactone treatment on an experimental model of chronic aortic valve regurgitation. J Heart Valve Dis 21, 478-486.
61. Zheng J, Chen Y, Pat B, Dell'Italia LA, Tillson M, Dillon AR, Powell PC, Shi K, Shah N, Denney T, Husain A & Dell'Italia LJ (2009). Microarray identifies extensive downregulation of noncollagen extracellular matrix and profibrotic growth factor genes in chronic isolated mitral regurgitation in the dog. Circulation 119, 2086-2095.